Determination of A-Protein Levels in Adult and Pediatric Brain Tumor Patients
- Patients will be identified at the time of presentation to their neurologist,
neurosurgeon or oncologist.
- Blood or cerebrospinal fluid will be collected for this study only when they are being
collected for other reasons before and after each surgery. Samples will also be
collected after any event such as significant change in symptoms or radiographic
- Once the patients condition has been stabilized, samples will be take at regular
intervals of >= 1 month. The duration of this study is 24 months.
Observational Model: Case-Only, Time Perspective: Prospective
The purpose of this study is to evaluate the usefulness of a molecule called "A-Protein" in the diagnosis and evaluation of patients with central nervous system disorders.
Mark W Kieran, MD,PhD
Dana-Farber Cancer Institute
United States: Institutional Review Board
|Dana Farber Cancer Institite||Boston, Massachusetts 02115|